| Name |
|---|
TLCD2 GeneTLC domain containing 2 Involved in several processes, including membrane assembly; phospholipid homeostasis; and regulation of membrane lipid distribution. Located in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TLCD1 GeneTLC domain containing 1 Involved in several processes, including membrane assembly; phospholipid homeostasis; and regulation of membrane lipid distribution. Located in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TLCD3A GeneTLC domain containing 3A The protein encoded by this gene is a membrane-associated protein that promotes lung carcinogenesis. The encoded protein may be involved in amino acid transport and glutathione metabolism since it can interact with a solute carrier family member (SLC3A2) and an isoform of gamma-glutamyltranspeptidase-like 3. An alternatively spliced variant encoding a protein that lacks a 32 aa internal segment showed the opposite effect, inhibiting lung cancer cell growth. Knockdown of this gene also inhibited lung carcinogenesis and tumor cell growth. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2015] |
TLCD4 GeneTLC domain containing 4 Predicted to be involved in lipid homeostasis. Predicted to be located in membrane. Predicted to be active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Mar 2025] |
TLCD5 GeneTLC domain containing 5 Predicted to be located in membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TLCD3B GeneTLC domain containing 3B This gene encodes a transmembrane protein, which may be a likely target of peroxisome proliferator-activated receptor gamma (PPAR-gamma). The product of the orthologous gene in mouse is related to obesity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016] |
TLC-388 Gene Setinteracting proteins for the TLC-388 drug from theDGIdb Drug Targets 2026 dataset. |